News & Updates
Filter by Specialty:
Show Multimedia Only

Does CKD reduce tirzepatide benefits on HFpEF patients with obesity?
15 Apr 2025
byStephen Padilla
Long-term treatment with tirzepatide results in improved renal function in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, regardless of the absence or presence of chronic kidney disease (CKD), according to a post hoc analysis of the SUMMIT trial presented at ACC.25.
Does CKD reduce tirzepatide benefits on HFpEF patients with obesity?
15 Apr 2025
TB vax primer augments BCG-induced immune response in bladder cancer patients
15 Apr 2025
byAudrey Abella
Initial results of the phase I RUTIVAC-1 study show the potential of two doses of a tuberculosis (TB) vaccine given after surgery but before standard BCG* treatment to boost immunity and reduce the odds of recurrence in patients with non-muscle-invasive bladder cancer (NMIBC).